Autolus Therapeutics PLC (NASDAQ:AUTL)

2.91
Delayed Data
As of Jun 02
 -0.23 / -7.35%
Today’s Change
1.60
Today|||52-Week Range
3.79
+53.16%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Autolus Therapeutics PLC have a median target of 6.00, with a high estimate of 12.00 and a low estimate of 2.70. The median estimate represents a +106.19% increase from the last price of 2.91.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Autolus Therapeutics PLC. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.22
Sales
$117.0K
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 2.78%
 
 
 
 
 
 
Growthannually 44.70%
 
 
 
 
 
 

Sales

Growthquarterly -90.94%
 
 
 
 
 
 
Growthannually 32.01%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.